Masterclass in Clinical Oncology - Summer edition

Chairs: F. A. Peccatori, IT – H. Azim Jr, EG
Host Chairs: P. Casali, IT – B. Vincenzi, IT

Aims, objectives and teaching format

The ESO Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists with 3-4 years experience in oncology who would like to receive further training on the treatment of tumours from a multidisciplinary point of view. The programme exposes participants to a full spectrum of issues in clinical oncology and to practice-oriented training.
The Masterclass is organized into:

• Plenary lectures on state-of-the-art clinical treatments with reference to clinical guidelines given by renowned international faculty.
• Interactive workshops on how to write and publish a paper, communication, how to deal with data uncertainty and managing burnout.
• Clinical case presentations/tumour board simulation where each participant presents and discusses a case with an international faculty of top experts in each tumour type.

The Masterclass is divided into two educational parts:

1. Pre-recorded online lectures
2. In-person event

The online lectures are released before the in-person event to give each participant the opportunity to prepare themselves in their own time and at their own pace.

The in-person event is held in the style of a 3-and-half-day ‘retreat’, giving participants the opportunity to begin building an international oncology network as well as the chance to interact with renowned faculty in an informal environment over a number of days.

The Masterclass is held entirely in English and fluency in English is necessary for admission.

The ESO Masterclass in Clinical Oncology: Summer edition is a closed event for selected participants only.

LANGUAGE

The Masterclass will be held in English and translation will not be provided.

FEE

The Masterclass will take place at Università Campus Bio-Medico di Roma, Rome, Italy.

A fee of:

• 300 EUR for participant working in High-Middle Income Countries *
• 200 EUR for participants working in Low-Middle income countries *

covers:

• Access to the course and its educational resources
• Accommodation for 4 nights 
• Group transfer to and from the Masterclass venue, each day of the course 
• Meals according to the programme

The fee does not cover travel costs, these should be organized and paid by the participant.

A discount of 100 EUR is given to participants who are already ESCO members.

*as defined by the World Bank

The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.

ACCREDITATION

Participants will be issued a certificate of attendance (minimum attendance: 75% of the online part + 100% of the in-person event). An online evaluation questionnaire and learning assessment test will need to be completed for both parts in order to get the certificate that will be sent by email.
The Accreditation Council of Oncology in Europe (ACOE) has awarded 43 credits to this activity. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

     ESCO - The ESO College

Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enroll in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

ORGANISING SECRETARIAT

Alice Ciocchini
European School of Oncology
ph +39 335 133 28 33
e-mail: aciocchini@eso.net

Dolores Knupfer
European School of Oncology
ph +41 91 820 09 50
e-mail: dknupfer@eso.net

APPLICATIONS CLOSED

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY

60 PARTICIPANTS WILL BE SELECTED.

Applications deadline: 31^st March 2024

IDEAL PROFILE OF THE MASTERCLASS CANDIDATE

• Aged up to 40 years
• 2-3 years’ experience in medical oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
• From ESO’s geographical reach: Europe, Mediterranean countries and Latin America

HOW TO APPLY

Interested oncologists should apply online (at the top of this page) providing:

• Letter describing motivation for attending
• Supporting letter from head of department or mentor
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
• Clinical case (please, use the provided template - Download HERE)
• Professional experience form (please, use the provided template - Download HERE)

CLINICAL CASE PRESENTATION

During the in-person selected participants will have the chance to present a clinical case as a clinical grandround discussion to the faculty and participants. A template giving details of the clinical case you would like to present should be submitted with your application. Please provide a straightforward case found in your daily clinical practice - no uncommon or extremely rare cases. 

You should include:

• Diagnostic considerations
• Treatment
• Results, follow-up
• At least three questions proposed for discussion with the faculty

If you are selected for the Masterclass, you will be asked to prepare a PowerPoint presentation of your case (max 10 slides). If we receive too many cases from one tumour group, we may ask you to change the case topic you submitted during your application. We kindly ask you to let us know your 2^nd choice topic if your first choice cannot be accommodated.

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Clinical Case template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

Roberto Angioli, University Campus Bio-Medico, Gynaecological Cancer Dpt., Rome, IT
Riccardo A. Audisio, Trieste, IT
Hatem A. Azim Jr., Cairo Cure Oncology Center , Cairo, EG
Giulia Baciarello, San Camillo-Forlanini Hospitals, Genitourinary Oncology Dpt., Rome, IT
Joerg Beyer, University Hospital of Bern, Oncology and Medicine Dept., Bern, CH
Justyna Bochenek-Cibor, St' Lukas Hospital, Radiation Therapy Dpt., Tarnów, PL
Paolo Bruzzi, Genova, IT
Felipe A. Calvo Manuel, Clinica Universidad de Navarra, Dept. of Radiation Oncology, Madrid, ES
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Paolo Giovanni Casali, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milan, IT
Franco Cavalli, Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH
Ian Chau, Royal Marsden Hospital, Department of Medicine, Sutton, Surrey, UK
Paola Collini, National Cancer Institute - IRCCS Foundation, Milan, IT
Nicoletta Colombo, Istituto Europeo di Oncologia, Programma Ginecologia Oncologica, Milano, IT
Alessio Cortellini, University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT
Carmen Criscitiello, European Institute of Oncology, New Drugs and Early Drug Development for Innovative Therapies Dpt., Milan, IT
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Alessandra Curioni-Fontecedro, Freiburger Spital, HFR Kantonsspital Freiburg, Department of Oncology, Freiburg, CH
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Francesca Del Bufalo, IRCCS Peadiatric Hospital Bambino Gesù, Cellular and Genic Therapy Dpt., Roma, IT
Andre D'Hoore, UZ Gasthuisberg, Dept. of Surgery, Leuven, BE
Antonio Di Meglio, Gustave Roussy Institute, Medical Oncology Dpt., Villejuif, FR
Andreas Dietz, University Hospital Leipzig, ENT Dpt., Leipzig, DE
Alexandru Eniu, Riviera-Chablais Hospital, Medical Oncology, Rennaz, CH
Andrea Ferrari, Fondazione IRCCS Istituto Nazionale dei Tumori, Div. di Oncologia Pediatrica, Milano, IT
Marco Fiore, National Cancer Institute - IRCCS Foundation, Surgery Dpt., Milan, IT
Martin Früh, St. Gallen Cantonal Hospital, Dept. of Internal Medicine, St. Gallen, CH
Andrea Gallina, EOC - Ente Ospedaliero Cantonale, Urology Dpt., Bellinzona, CH
Fady B. Geara, Cleveland Clinic Abu Dhabi, Dept. of Radiation Oncology, Abu Dhabi, AE
Juan Francisco Grau Bejar, Vall d´Hebron University Hospital, Gynaecological Cancer Dpt., Barcelona, ES
Alessandro Gronchi, National Cancer Institute - IRCCS Foundation, Sarcomas Surgery Unit, Milano, IT
Edy Ippolito, University Campus Bio-Medico, Breast Cancer Dpt., Rome, IT
Barbara Alicja Jereczek-Fossa, European Institute of Oncology, Dept. of Radiotherapy, Milan, IT
Angela Lamarca, Fundación Jiménez Díaz University Hospital, Department of Oncology – OncoHealth Institute, Madrid, ES
Olivia Le Saux, Centre Leon Berard, Oncology Dpt., Lyon, FR
Pauline Leonard, National Health Service, Oncology and Communication Dpt., London, UK
Florian Lordick, University Hospital Leipzig, University Cancer Center Leipzig (UCCL), Leipzig, DE
Umberto Malapelle, University of Naples Federico II, Dpt. of Public Health, QUARTO, IT
Olivier Michielin, Geneve University Hospital, Medical Oncology Dpt., Geneve, CH
Giannis Mountzios, University of Athens School of Medicine, Dept. of Medical Oncology, Athens, GR
Jarushka Naidoo, Waterford Regional Hospital, Medical Oncology Dpt., Waterford, IE
Federico Navarria, Oncology Center (CRO), Radiotherapy Dpt., Aviano, IT
Andrea Necchi, IRCCS San Raffaele Hospital, Genitourinary Medical Oncology Division, Milan, IT
Christoph Oing, Newcastle upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Newcastle Upon Tyne, UK
Demetris Papamichael, Bank of Cyprus Oncology Centre, Medical Oncology Dpt., Nicosia, CY
Anes Pasic, University Clinical Center Maribor (UKC Maribor), Oncology Dept., Maribor, SI
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Giuseppe Perrone, University Campus Bio-Medico, Pathology Anatomy Dpt., Rome, IT
Filippo Pietrantonio, IRCCS Istituto Nazionale dei Tumori, Gastro-intestinal cancers Dpt., Milano, IT
Philip Poortmans, Sint Augustus Hospital, Radiotherapy Dept., Wilrijk, BE
Eleonora Petra Preti, IEO - European Institute of Oncology, Gynaecological Cancer Dpt., Milan, IT
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Amanda Psyrri, Attikon University Hospital, Medical Oncology Dept., Chaidari, GR
Sara Ramella, University Campus Bio-Medico, Radiotherapy Dpt., Roma, IT
Isabelle Ray-Coquard, Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Erino Angelo Rendina, Universiry of Rome, Thoracic Surgery Dpt., Rome, IT
Christian Rolfo, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Center for Thoracic Oncology, New York, US
Laura Rubbia-Brandt, Hôpitaux Universitaires Genève, Pathology Dept., Geneve, CH
Marzia Salgarello, Policlinico Gemelli, Recostructive Surgery Dpt., Rome, IT
Manuela Schmidinger, Medical University of Vienna, Department of Urology and Comprehensive Cancer Center, Vienna, AT
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Isabelle Schmitt-Opitz, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH
Joachim Schuz, AIRC - International Agency for Research on Cancer, Environment and Lifestyle Epidemiology Branch, Lyon, FR
Cristiana Sessa, IOSI - Oncology Institute of Southern Switzerland, Gynaecology Dpt., Bellinzona, CH
Thomas Seufferlein, Ulm University Hospital, Dept. of Internal Medicine I, Ulm, DE
Alina Sturdza, Comprehensive Cancer Center, Medical University of Vienna, Dept. of Radiation Oncology, Wien, AT
Ian Tannock, Toronto, CA
Daniela Andreina Terribile, Università Cattolica Sacro Cuore and Isola Tiberina Gemelli Hospital, Rome, IT
Annalisa Trama, Milano, IT
Eric Van Cutsem, University Hospital Leuven, Digestive Oncology Dept., Leuven, BE
Alberto Vannelli, Ospedale Valduce, General Surgery Dpt., Como, IT
Bruno Vincenzi, University Campus Bio-Medico, Medical Oncology Dpt., Rome, IT
Marco Vitellaro, National Cancer Institute - IRCCS Foundation, General Surgery Dpt., Milano, IT
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
Gian Franco Zannoni, Policlinico Gemelli, Anatomo-pathology Dpt., Rome, IT